Home
/
Online library
/
Scientific papers / HPV
Publications / HPV
Topics:
Peer-reviewed journal articles:
| Arbyn M., Costa S., Latsuzbaia A., Kellen E., Girogi Rossi P., Cocuzza C.E., Basu P., Castle P.E. HPV-based Cervical Cancer Screening on Self-samples in the Netherlands: Challenges to Reach Women and Test Performance Questions. Cancer Epidemiol Biomarkers Prev. 2023 Feb 6;32(2):159-163. PMID: 36744312 |
| Bhatla N., Muwonge R., Malvi S.G., Joshi S., Poli U.R.R., Lucas E., Esmy P.O., Verma Y., Shah A., Zomawia E., Pimple S., Jayant K., Hingmire S., Chiwate A., Vashist S., Mishra G., Jadhav R., Siddiqi M., Anantharaman D., Panicker G., Butt J., Sankaran S., Kannan T.P.R.A., Varghese R., Kartha P., Pillai M.R., Waterboer T., Muller M., Sehr P., Unger E.R., Sankaranarayanan R., Basu P. Impact of age at vaccination and cervical HPV infection status on binding and neutralizing antibody titers at 10 years after receiving single or higher doses of quadrivalent HPV vaccine. Hum Vaccin Immunother. 2023 Dec 15;19(3):2289242. doi: 10.1080/21645515.2023.2289242. PMID: 38078840 |
| Gheit T., Muwonge R., Lucas E., Galati L., Anantharaman D., McKay-Chopin S., Malvi S.G., Jayant K., Joshi S., Esmy P.O., Pillai M.R., Basu P., Sankaranarayanan R., Tommasino M. Impact of HPV vaccination on HPV-related oral infections. Oral Oncol. 2023 Jan;136:106244. PMID: 36402055 |
| Ibrahim Khalil A., Zhang L., Muwonge R., Sauvaget C., Basu P. Efficacy and safety of therapeutic HPV vaccines to treat CIN 2/CIN 3 lesions: a systematic review and meta-analysis of phase II/III clinical trials. BMJ Open. 2023 Oct 24;13(10):e069616. PMID: 37879679 |
| Joshi S., Anantharaman D., Muwonge R., Bhatla N., Panicker G., Butt J., Rani Reddy Poli U., Malvi S.G., Esmy P.O., Lucas E., Verma Y., Shah A., Zomawia E., Pimple S., Jayant K., Hingmire S., Chiwate A., Divate U., Vashist S., Mishra G., Jadhav R., Siddiqi M., Sankaran S., Pillai Rameshwari Ammal Kannan T., Kartha P., Shastri S.S., Sauvaget C., Radhakrishna Pillai M., Waterboer T., Muller M., Sehr P., Unger E.R., Sankaranarayanan R., Basu P. Evaluation of immune response to single dose of quadrivalent HPV vaccine at 10-year post-vaccination. Vaccine. 2023 Jan 4;41(1):236-245. PMID: 36446654 |
| M de Carvalho T., Man I., Georges D., Saraswati L.R., Bhandari P., Kataria I., Siddiqui M., Muwonge R., Lucas E., Sankaranarayanan R., Basu P., Berkhof J., Bogaards J.A., Baussano I. Health and economic effects of introducing single-dose or two-dose human papillomavirus vaccination in India. BMJ Glob Health. 2023 Nov;8(11):e012580. PMID: 37931940 |
| Mullapally S.K., Basu P, Parikh P. Prevention of Cervical Cancer through HPV Vaccination and Screening in Maldives. South Asian J Cancer. 2023 Feb 25;12(1):44-46. PMID: 36851935 |
| Muwonge R., Basu P.; IARC-India HPV vaccine study consortium. Re: Using observational data to explore the hypothesis that a single dose of current HPV vaccines can provide durable protection: Reply to the commentary written by Christine Velicer, Alain Luxembourg, Ya-Ting Chen, Melvin Kohn, and Alfred Saah, Merck & Co., Inc., Kenilworth, NJ, USA on the IARC-India HPV vaccine study. Vaccine. 2023 Jun 14:S0264-410X(23)00696-5. PMID: 37328351 |
| Ong S.K., Abe S.K., Thilagaratnam S., Haruyama R., Pathak R., Jayasekara H., Togawa K., Bhandari A.K.C., Shankar A., Nessa A., Jugder U., Agustina J., Biglari M., Yusuf A., Tshomo U., Fernando E., Cairo C., Kaung K.K., Rath B., Vongdala C., Pradhananga K.K., Kim J., Chung Y.K., Thanh Huong T.T., Sangrajran S., Zhang Y., Basu P., Woo Y.L., Sukumaran B., Hwang W.Y.K. Towards elimination of cervical cancer - human papillomavirus (HPV) vaccination and cervical cancer screening in Asian National Cancer Centers Alliance (ANCCA) member countries. Lancet Reg Health West Pac. 2023 Aug 1;39:100860. PMID: 37576906 |
| Oommen A.M., Basu P., Cherian A.G., Zomawia E., Manoharan R., Pricilla R.A., Viswanathan V., Oldenburg B., Subramanian S., Hawkes D., Saville M., Brotherton J.M.L.; SHE-CAN collaborators. Protocol for the formative phase of a trial (SHE-CAN) to test co-designed implementation strategies for HPV-based cervical screening among vulnerable women in two diverse settings in India. Implement Sci Commun. 2023 Jun 8;4(1):62. PMID: 37291627 |
| Sangrajrang S., Pitakkarnkul S., Muwonge R., Ploysawang P., Pangmuang P., Seeda K., Basu P. Agreement between Self- and Physician-Sampling for Detection of High-Risk Human Papillomavirus Infections in Women Attending Cervical Screening at National Cancer Institute, Thailand. Asian Pac J Cancer Prev. 2023 Aug 1;24(8):2615-2619. PMID: 37642046 |
| Sharma H., Parekh S., Pujari P., Shewale S., Desai S., Bhatla N., Joshi S., Pimple S., Kawade A., Balasubramani L., Thomas A., Suri V., Lalwani S., Uday R., Kamath V., Mandal R., Rajeswar A., Peedicayil A., Poli U.R., Banerjee D., Sankaranarayanan R., Basu P., Muwonge R., Gairola S., Dogar V., Rao H., Shaligram U. Immunogenicity and safety of a new quadrivalent HPV vaccine in girls and boys aged 9-14 years versus an established quadrivalent HPV vaccine in women aged 15-26 years in India: a randomised, active-controlled, multicentre, phase 2/3 trial. Lancet Oncol. 2023 Dec;24(12):1321-1333. doi: 10.1016/S1470-2045(23)00480-1. PMID: 37949086 |
| Simms K.T., Keane A., Nguyen D.T.N., Caruana M., Hall M.T., Lui G., Gauvreau C., Demke O., Arbyn M., Basu P., Wentzensen N., Lauby-Secretan B., Ilbawi A., Hutubessy R., Almonte M., De Sanjose S., Kelly H., Dalal S., Eckert L.O., Santesso N., Broutet N., Canfell K. Benefits, harms and cost-effectiveness of cervical screening, triage and treatment strategies for women in the general population. Nat Med. 2023 Dec;29(12):3050-3058. doi: 10.1038/s41591-023-02600-4. PMID: 38087115 |
| Sun L., Patel S., Fiorina C., Glass A., Rochaix L.; CBIG-SCREEN Consortium; Foss AM, Legood R. A systematic review of the cost-effectiveness of interventions to increase cervical cancer screening among underserved women in Europe. Eur J Health Econ. 2023 Sep 20. doi: 10.1007/s10198-023-01627-1. PMID: 37726429 |
| Taghavi K., Moono M., Mwanahamuntu M., Roumet M., Limacher A., Kapesa H., Madliwa T., Rutjes A., Basu P., Low N., Manasyan A., Bohlius J. Accuracy of screening tests for cervical pre-cancer in women living with HIV in low-resource settings: a paired prospective study in Lusaka, Zambia. medRxiv. 2023 Jun 1:2023.05.31.23290779. PMID: 37398043 |
| Taghavi K., Zhao F., Downham L., Baena A., Basu P. Molecular triaging options for women testing HPV positive with self-collected samples. Front Oncol. 2023 Sep 22;13:1243888. PMID: 37810963 |
| Zhao X.L., Zhao S., Xia C.F., Hu S.Y., Duan X.Z., Liu Z.H., Wang Y.Y., You T.T., Gao M., Qiao Y.L., Basu P., Zhao F.H. Cost-effectiveness of the screen-and-treat strategies using HPV test linked to thermal ablation for cervical cancer prevention in China: a modeling study. BMC Med. 2023 Apr 17;21(1):149. PMID: 37069602 |
| Asangbeh-Kerman S.L., Davidovic M., Taghavi K., Kachingwe J., Rammipi K.M., Muzingwani L., Pascoe M., Jousse M., Mulongo M., Mwanahamuntu M., Tapela N., Akintade O., Basu P., Dlamini X., Bohlius J. Cervical cancer prevention in countries with the highest HIV prevalence: a review of policies. BMC Public Health. 2022 Aug 10;22(1):1530. PMID: 35948944 |
| Baisley K., Kemp T.J., Kreimer A.R., Basu P., Changalucha J., Hildesheim A., Porras C., Whitworth H., Herrero R., Lacey C.J., Schiller J.T., Lucas E., Mutani P., Dillner J., Indangasi J., Muwonge R., Hayes R.J., Pinto L.A., Watson-Jones D. Comparing one dose of HPV vaccine in girls aged 9-14 years in Tanzania (DoRIS) with one dose of HPV vaccine in historical cohorts: an immunobridging analysis of a randomised controlled trial. Lancet Glob Health. 2022 Oct;10(10):e1485-e1493. PMID: 36113532 |
| Basu P., Muwonge R. Alternative analysis of the data from a HPV vaccine study in India - Authors' reply. Lancet Oncol. 2022 Jan;23(1):e10. PMID: 34973220 |
| Broutet N., Jeronimo J., Kumar S., Almonte M., Murillo R., Huy N.V.Q., Denny L., Kapambwe S., Bhatla N., Sebitloane M., Zhao F., Gravitt P., Adsul P., Rangaraj A., Dalal S., Newman M., Chowdhury R., Church K., Nakisige C., Diop M., Parham G., Thomson K.A., Basu P., Steyn P. Implementation research to accelerate scale-up of national screen and treat strategies towards the elimination of cervical cancer. Prev Med. 2021 Dec 8;106906. PMID: 34896155 |
| Joshi S., Muwonge R., Kulkarni V., Mandolkar M., Lucas E., Pujari S., Sankaranarayanan R., Basu P. Can we increase the cervical cancer screening interval with an HPV test for women living with HIV? Results of a cohort study from Maharashtra, India. Int J Cancer. 2022 Jul 19. PMID: 35852007 |
| Man I., Georges D., de Carvalho T.M., Ray Saraswati L., Bhandari P., Kataria I., Siddiqui M., Muwonge R., Lucas E., Berkhof J., Sankaranarayanan R., Bogaards J.A., Basu P., Baussano I. Evidence-based impact projections of single-dose human papillomavirus vaccination in India: a modelling study. Lancet Oncol. 2022 Nov;23(11):1419-1429. PMID: 36174583 |
| Prudden H.J., Achilles S.L., Schocken C., Broutet N., Canfell K., Akaba H., Basu P., Bhatla N., Chirenje Z.M., Delany-Moretlwe S., Denny L., Gamage D.G., Herrero R., Hutubessy R., Villa L.L., Murillo R., Schiller J.T., Stanley M., Temmerman M., Zhao F., Ogilvie G., Kaslow D.C., Dull P., Gottlieb S.L.; Therapeutic HPV Vaccine PPC Expert Consultation Group*. Understanding the public health value and defining preferred product characteristics for therapeutic human papillomavirus (HPV) vaccines: World Health Organization consultations, October 2021-March 2022. Vaccine. 2022 Sep 29;40(41):5843-5855. PMID: 36008233 |
| Rol M.L., Picconi M.A., Ferrera A., Sanchez G.I., Hernandez M.L., Lineros J., Peraza A., Brizuela M., Mendoza L., Mongelos P., Cabrera Y., Rodriguez de la Pena M., Correa R.M., Teran C., Colque Reynaga D., Garcia L., Ramirez A.T., Hernandez-Nevarez P., Doimi F., Ramon M., Arias-Stella J., Zuniga M., Villagra V., Bobadilla M.L., Cardinal L., Valls J., Lucas E., Baena A., Fleider L., Venegas G., Cruz-Valdez A., Rodriguez G., Calderon A., Wiesner C., Luciani S., Broutet N., Herrero R., Almonte M. Implementing HPV testing in 9 Latin American countries: The laboratory perspective as observed in the ESTAMPA study. Front Med (Lausanne). 2022 Nov 17;9:1006038. PMID: 36465901 |
| Simoens C., Gheit T., Ridder R., Gorbaslieva I., Holzinger D., Lucas E., Rehm S., Vermeulen P., Lammens M., Vanderveken O.M., Kumar R.V., Gangane N., Caniglia A., Maffini F., Rubio MB.L., Anantharaman D., Chiocca S., Brennan P., Pillai M.R., Sankaranarayanan R., Bogers J., Pawlita M., Tommasino M., Arbyn M.; HPV-AHEAD study group. Accuracy of high-risk HPV DNA PCR, p16(INK4a) immunohistochemistry or the combination of both to diagnose HPV-driven oropharyngeal cancer. BMC Infect Dis. 2022 Aug 6;22(1):676. PMID: 35933382 |
| Zhang L., Zhao X., Hu S., Chen S., Zhao S., Dong L., Carvalho A.L., Muwonge R., Zhao F., Basu P. Triage performance and predictive value of the human gene methylation panel among women positive on self-collected HPV test: results from a prospective cohort study. Int J Cancer. 2022 Apr 22. doi: 10.1002/ijc.34041. PMID: 35460075 |
| Zhang L., Zhao X., Hu S., Chen S., Zhao S., Dong L., Carvalho A.L., Muwonge R., Zhao F., Basu P. Triage performance and predictive value of the human gene methylation panel among women positive on self-collected HPV test: Results from a prospective cohort study. Int J Cancer. 2022 Sep 15;151(6):878-887. PMID: |
| Basu P., Malvi S.G., Joshi S., Bhatla N., Muwonge R., Lucas E., Verma Y., Esmy P., Poli U.R.R., Shah A., Zomawia E., Pimple S., Jayant K., Hingmire S., Chiwate A., Divate U., Vashist S., Mishra G., Jadhav R., Siddiqi M., Sankaran S., Prabhu P.R., Kannan T.P.R.A., Varghese R., Shastri S.S., Anantharaman D., Gheit T., Tommasino M., Sauvaget C., Pillai M.R., Sankaranarayanan R. Vaccine efficacy against persistent human papillomavirus (HPV) 16/18 infection at 10 years after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre, prospective, cohort study. Lancet Oncol, Published online 8 October 2021. PMID: 34634254 |
| Bhatla N., Aoki D., Sharma D.N., Sankaranarayanan R. Cancer of the cervix uteri: 2021 update. Int J Gynaecol Obstet. 2021 Oct;155 Suppl 1:28-44. PMID: 34669203 |
| Bouvard V., Wentzensen N., Mackie A., Berkhof J., Brotherton J., Giorgi-Rossi P., Kupets R., Smith R., Arrossi S., Bendahhou K., Canfell K., Chirenje Z.M., Chung M.H., Del Pino M., de Sanjose S., Elfstrom M., Franco E.L., Hamashima C., Hamers F.F., Herrington C.S., Murillo R., Sangrajrang S., Sankaranarayanan R., Saraiya M., Schiffman M., Zhao F., Arbyn M., Prendiville W., Indave Ruiz B.I., Mosquera-Metcalfe I., Lauby-Secretan B. The IARC Perspective on Cervical Cancer Screening. N Engl J Med. 2021 Nov 11;385(20):1908-1918. PMID: 34758259 |
| Broutet N., Jeronimo J., Kumar S., Almonte M., Murillo R., Huy N.V.Q., Denny L., Kapambwe S., Bhatla N., Sebitloane M., Zhao F., Gravitt P., Adsul P., Rangaraj A., Dalal S., Newman M., Chowdhury R., Church K., Nakisige C., Diop M., Parham G., Thomson K.A., Basu P., Steyn P. Implementation research to accelerate scale-up of national screen and treat strategies towards the elimination of cervical cancer. Prev Med. 2021 Dec 8;106906. PMID: 34896155 |
| Mariz F.C., Bender N., Anantharaman D., Basu P., Bhatla N., Pillai M.R., Prabhu P.R., Sankaranarayanan R., Eriksson T., Pawlita M., Prager K., Sehr P., Waterboer T., Muller M., Lehtinen M. Peak neutralizing and cross-neutralizing antibody levels to human papillomavirus types 6/16/18/31/33/45/52/58 induced by bivalent and quadrivalent HPV vaccines. NPJ Vaccines. 2020 Feb 14;5(1):14. PMID: 33580075 |
| Ritchie D., Arbyn M., Basu P., Corbex M., Fidarova E., Ivanuš U., Papi G., Torode J., Zacharopoulou C. Europe's Path to Eliminating Cervical Cancer as a Public Health Problem. Lancet Reg Health Eur. 2022;12:100276. PMID: 34901914 |
| Simoens C., Gorbaslieva I., Gheit T., Holzinger D., Lucas E., Ridder R., Rehm S., Vermeulen P., Lammens M., Vanderveken O.M., Kumar R.V., Gangane N., Caniglia A., Maffini F., Rubio M.B.L. , Anantharaman D., Chiocca S., Brennan P., Pillai M.R., Sankaranarayanan R., Bogers J., Pawlita M., Tommasino M., Arbyn M., HPV-AHEAD study group. HPV DNA genotyping, HPV E6*I mRNA detection, and p16 INK4a/Ki-67 staining in Belgian head and neck cancer patient specimens, collected within the HPV-AHEAD study. Cancer Epidemiol. 2021 Apr 8;72:101925. PMID: 33839457 |
| Wentzensen N., Chirenje Z.M., Prendiville W. Treatment approaches for women with positive cervical screening results in low-and middle-income countries. Prev Med. 2021 Mar;144:106439 PMID: 33678236 |
| Zhao S., Huang L., Basu P., Domingo E.J., Supakarapongkul W., Ling W.Y., Ocviyanti D., Rezhake R., Qiao Y., Tay E.H., Zhao F. Cervical cancer burden, status of implementation and challenges of cervical cancer screening in Association of Southeast Asian Nations (ASEAN) countries. Cancer Letters 525 (2022) 22–32. PMID: 34728309 |
| Almonte M., Murillo R., Sanchez G.I., Gonzalez P., Ferrera A., Picconi M.A., Wiesner C., Cruz-Valdez A., Lazcano-Ponce E., Jeronimo J., Ferreccio C., Kasamatsu E., Mendoza L., Rodriguez G., Calderon A., Venegas G., Villagra V., Tatti S., Fleider L., Teran C., Baena A., Hernandez M.L., Rol M.L., Lucas E., Barbier S., Ramirez A.T., Arrossi S., Rodriguez M.I., Gonzalez E., Celis M., Martinez S., Salgado Y., Ortega M., Beracochea A.V., Perez N., Rodriguez de la Pena M., Ramon M., Hernandez-Nevarez P., Arboleda-Naranjo M., Cabrera Y., Salgado B., Garcia L., Retana M.A., Colucci M.C., Arias-Stella J., Bellido-Fuentes Y., Bobadilla M.L., Olmedo G., Brito-Garcia I., Mendez-Herrera A., Cardina L., Flores B., Penaranda J., Martinez-Better J., Soilan A., Figueroa J., Caserta B., Sosa C., Moreno A., Mural J., Doimi F., Gimenez D., Rodriguez H., Lora O., Luciani S., Broutet N., Darragh T., Herrero R. Multicentric study of cervical cancer screening with human papillomavirus testing and assessment of triage methods in Latin America: the ESTAMPA screening study protocol. BMJ Open 2020;10:e035796. PMID: 32448795 |
| Arbyn M., Bruni L., Kelly D., Basu P., Poljak M., Gultekin M., Bergeron C., Ritchie D., Weiderpass E. Tackling cervical cancer in Europe amidst the COVID-19 pandemic. Lancet Public Health. 2020 Jul 13;S2468-2667(20)30122-5. PMID: 32673570 |
| Arbyn M., Gultekin M., Morice P., Nieminen P., Cruickshank M., Poortmans P., Kelly D., Poljak M., Bergeron C., Ritchie D., Schmidt D., Kyrgiou M., Van den Bruel A., Bruni L., Basu P., Bray F., Weiderpass E. The European Response to the WHO Call to Eliminate Cervical Cancer as a Public Health Problem. Int J Cancer. 2020 Jul 7. PMID: 32638362 |
| Armaroli P., Riggi E., Basu P., Anttila A., Ponti A., Carvalho A.L., Dillner J., Elfstrom M.K., Giordano L., Lonnberg S., Ronco G., Senore C., Soerjomataram I., Tomatis M., Vale D.B., Jarm K., Sankaranarayanan R., Segnan N. Performance Indicators in Breast Cancer Screening in the European Union: A Comparison Across Countries of Screen Positivity and Detection Rates. Int J Cancer. 2020 Mar 11. PMID: 32159224 |
| Baena A., De Vuyst H., Mesher D., Kasubi M., Yuma S., Mwaiselage J., Zouiouich S., Mlay P., Kahesa C., Landoulsi S., Hernandez M.L., Lucas E., Herrero R., Almonte M., Broutet N. Reproducibility of a rapid human papillomavirus test at different levels of the healthcare system in Tanzania: the AISHA study. Cancer Epidemiol Biomarkers Prev. August 20 2020. PMID: 32856600 |
| Banerjee D., Mandal R., Mandal A., Ghosh I., Mittal S., Muwonge R., Lucas E., Basu P. A Prospective Randomized Trial to Compare Safety, Acceptability and Efficacy of Thermal Ablation and Cryotherapy in a Screen and Treat Setting. Asian Pac J Cancer Prev. 2020 May 1;21(5):1391-1398. PMID: 32458647 |
| Bhatla N., Meena J., Gupta K., Pal B., Divakar H., Bhalerao S., Peedicayil A., Srivastava S., Basu P., Purandare C.N.; FOGSI Expert Group. Human papillomavirus vaccination: Good clinical practice recommendations from the Federation of Obstetric and Gynecological Societies of India. J Obstet Gynaecol Res. 2020 Jul 6. PMID: 32627278 |
| Castle P.E., Pierz A.J., Adcock R., Aslam S., Basu P.S., Belinson J.L., Cuzick J., El-Zein M., Ferreccio C., Firnhaber C., Franco E.L., Gravitt P.E., Isidean S.D., Lin J., Mahmud S.M., Monsonego J., Muwonge R., Ratnam S., Mahboobeh Safaeian M., Schiffman M., Smith J.S., Swarts A., Wright T., Van De Wyngard V., Xi L.F. A pooled analysis to compare the clinical characteristics of human papillomavirus-positive and -negative cervical precancers. Cancer Prev Res (Phila). 2020 Jul 12:canprevres.0182.2020. PMID: 32655005 |
| Escriva-Boulley G., Mandrik O., Preau M., Herrero R., Villain P. Cognitions and behaviours of general practitioners in France regarding HPV vaccination: A theory-based systematic review. Prev Med. 2020 Nov 7:106323. PMID: 33171178 |
| Kumar S., Khanduri A., Sidibe A., Morgan C., Torode J., Basu P., Bhatla N., Schocken C., Bloem P. Acting on the call: A framework for action for rapid acceleration of access to the HPV vaccination in low- and lower-middle-income countries. Int J Gynaecol Obstet. 2020 Nov 13. PMID: 33185283 |
| Mandal R., Ghosh I., Banerjee D., Mittal S., Muwonge R., Roy C., Panda C., Vernekar M., Frappart L., Basu P. Correlation Between p16/Ki-67 Expression and the Grade of Cervical Intraepithelial Neoplasias. Int J Gynecol Pathol. 2020 Jul;39(4):384-390. PMID: 32515923 |
| Mariz F.C., Bender N., Anantharaman D., Basu P., Bhatla N., Pillai M.R., Prabhu P.R., Sankaranarayanan R., Eriksson T., Pawlita M., Prager K., Sehr P., Waterboer T., Muller M., Lehtinen M. Peak neutralizing and cross-neutralizing antibody levels to human papillomavirus types 6/16/18/31/33/45/52/58 induced by bivalent and quadrivalent HPV vaccines. NPJ Vaccines. 2020 Feb 14;5:14. PMID: 32128255 |
| Muwonge R., Basu P., Gheit T., Anantharaman D., Verma Y., Bhatla N., Joshi S., Esmy P.O., Poli U.R.R., Shah A., Zomawia E., Shastri S.S., Pimple S., Prabhu P.R., Hingmire S., Chiwate A., Sauvaget C., Lucas E., Malvi S.G., Siddiqi M., Sankaran S., Kannan T.P.R.A., Varghese R., Divate U., Vashist S., Mishra G., Jadhav R., Tommasino M., Pillai M.R., Sankaranarayanan R., Jayant K.; Acquisition, prevalence and clearance of type-specific human papillomavirus infections in young sexually active Indian women: A community-based multicentric cohort study. Indian HPV vaccine study group. PLoS One. 2020 Dec 29;15(12):e0244242. PMID: 33373380 |
| Poli U.R., Muwonge R., Bhoopal T., Lucas E., Basu P. Feasibility, Acceptability, and Efficacy of a Community Health Worker-Driven Approach to Screen Hard-to-Reach Periurban Women Using Self-Sampled HPV Detection Test in India. JCO Glob Oncol. 2020 Apr;6:658-666. PMID: 32343627 |
| Shiko Y., Konno R., Konishi H., Sauvaget C., Ohashi Y., Kakizoe T. Effectiveness of HPV vaccination against the development of high-grade cervical lesions in young Japanese women. BMC Infect Dis. 2020 Nov 5;20(1):808. PMID: 33153446 |
| Tagliabue M., Mena M., Maffini F., Gheit T., Quiros Blasco B., Holzinger D., Tous S., Scelsi D., Riva D., Grosso E., Chu F., Lucas E., Ridder R., Rrehm S., Bogers J.P., Lepanto D., Lloveras Rubio B., Vijay Kumar R., Gangane N., Clavero O., Pawlita M., Anantharaman D., Radhakrishna Pillai M., Brennan P., Sankaranarayanan R., Arbyn M., Lombardi F., Taberna M., Gandini S., Chiesa F., Ansarin M., Alemany L., Tommasino M., Chiocca S., The Hpv-Ahead Study Group. Role of Human Papillomavirus Infection in Head and Neck Cancer in Italy: The HPV-AHEAD Study. Cancers (Basel). 2020 Nov 29;12(12):E3567. PMID: 33260360 |
| Tsang S.H., Basu P., Bender N., Herrero R., Kemp T.J., Kreimer A.R., Muller M., Panicker G., Pawlita M., Pinto L.A., Sampson J.N., Sankaranarayanan R., Schussler J., Sehr P., Sierra M.S., Unger E.R., Waterboer T., Hildesheim A.; Costa Rica Vaccine Trial (CVT) Group. Evaluation of serological assays to monitor antibody responses to single-dose HPV vaccines. Vaccine. 2020 Jul 23:S0264-410X(20)30917-8. PMID: 32713678 |
| Whitworth H.S., Gallagher K.E., Howard N., Mounier-Jack S., Mbwanji G., Kreimer A.R., Basu P., Kelly H., Drolet M., Brisson M., Watson-Jones D. Efficacy and immunogenicity of a single dose of human papillomavirus vaccine compared to no vaccination or standard three and two-dose vaccination regimens: A systematic review of evidence from clinical trials. Vaccine. 2019 Dec 20. pii: S0264-410X(19)31659-7. PMID: 31870572 |
| Zhao X.L., Liu Z.H., Zhao S., Hu S.Y., Muwonge R., Duan X.Z., Du L.J., Su C.F., Xiang X.E., Zhang X., Pan Q.J., Qiao Y.L., Sankaranarayanan R., Zhao F.H., Basu P. Efficacy of Point-of-care Thermal Ablation Among High-risk Human Papillomavirus Positive Women in China. Int J Cancer. 2020 Sep 7. PMID: 32895912 |
| Zhao X.L., Xu X.Q., Duan X.Z., Rezhake R., Hu S.Y., Wang Y., Xia C.F., Zhang X., Qiao Y.L., Sankaranarayanan R., Zhao F.H., Basu P. Comparative performance evaluation of different HPV tests and triaging strategies using self-samples and feasibility assessment of thermal ablation in 'colposcopy and treat' approach: a population-based study in rural China. Int J Cancer. 2020 Jan 22. PMID: 31970767 |
| Basu P., Hutubessy R., Broutet N. Cervical cancer: WHO called for elimination, not eradication. BMJ. 2019 Sep 26;366:l5668. PMID: 31558438 |
| Basu P., Mahajan M., Patira N., Prasad S., Mogri S., Muwonge R., Lucas E., Sankaranarayanan R., Iyer S., Naik N., Jain K. A pilot study to evaluate home-based screening for the common non-communicable diseases by a dedicated cadre of community health workers in a rural setting in India. BMC Public Health. 2019 Jan 3;19(1):14. PMID: 30606132 |
| Mahajan M., Naik N., Jain K., Patira N., Prasad S., Mogri S., Muwonge R., Lucas E., Faruq F., Sankaranarayanan R., Iyer S., Basu P. Study of Knowledge, Attitudes, and Practices Toward Risk Factors and Early Detection of Noncommunicable Diseases Among Rural Women in India. J Glob Oncol. 2019 Apr;(5):1-10. PMID: 30998427 |
| Ndizeye Z., Menon S., Van Geertruyden J.P., Sauvaget C., Jacquemyn Y., Bogers J.P., Benoy I., Vanden Broeck D. Performance of OncoE6TM Cervical Test in detecting cervical precancer lesions in HIV-positive women attending an HIV clinic in Bujumbura, Burundi: a cross-sectional study. BMJ Open. 2019 Sep 6;9(9):e029088. PMID: 31494606 |
| Sangrajrang S., Laowahutanont P., Wongsena M., Muwonge R., Imsamran W., Ploysawang P., Basu P. Human papillomavirus (HPV) DNA and mRNA primary cervical cancer screening: Evaluation and triaging options for HPV-positive women. J Med Screen. 2019 Jul 31. PMID: 31364471 |
| Sankaranarayanan R., Basu P., Kaur P., Bhaskar R., Singh G.B., Denzongpa P., Grover R.K., Sebastian P., Saikia T., Oswal K., Kanodia R., Dsouza A., Mehrotra R., Rath G.K., Jaggi V., Kashya S., Kataria I., Hariprasad R., Sasieni P., Bhatla N., Rajaraman P., Trimble E.L., Swaminathan S., Purushotham A. Current status of human papillomavirus vaccination in India's cervical cancer prevention efforts. Lancet Oncol. 2019 Nov;20(11):e637-e644. PMID: 31674322 |
| Two-dose recommendation for Human Papillomavirus vaccine can be extended up to 18 years - updated evidence from Indian follow up cohort study. Basu P., Muwonge R., Bhatla N., Nene B.M., Joshi S., Esmy P.O., Poli U.R.R., Joshi G., Verma Y., Zomawia E., Shastri S.S., Pimple S., Anantharaman D., Prabhu P.R., Hingmire S., Sauvaget C., Lucas E., Pawlita M., Gheit T., Jayant K., Malvi S.G., Siddiqi M., Michel A., Butt J., Sankaran S., Rameshwari Ammal Kannan T.P., Varghese R., Divate U., Willhauck-Fleckenstein M., Waterboer T., Muller M., Sehr P., Vashist S., Mishra G., Jadhav R., Thorat R., Tommasino M., Pillai M.R., Sankaranarayanan R.; Indian HPV vaccine study group. Papillomavirus Res. 2019 Jan 31. pii: S2405-8521(18)30133-2. PMID: 30711698 |
| Whitworth H.S., Gallagher K.E., Howard N., Mounier-Jack S., Mbwanji G., Kreimer A.R., Basu P., Kelly H., Drolet M., Brisson M., Watson-Jones D. Efficacy and immunogenicity of a single dose of human papillomavirus vaccine compared to no vaccination or standard three and two-dose vaccination regimens: A systematic review of evidence from clinical trials. Vaccine. 2019 Dec 20. pii: S0264-410X(19)31659-7. PMID: 31870572 |
| Garland S.M., Giuliano A., Brotherton J., Moscicki A.B., Stanley M., Kaufmann A.M., Bhatla N., Sankaranarayanan R., Palefsky J.M., de Sanjose S.; IPVS. IPVS statement moving towards elimination of cervical cancer as a public health problem. Papillomavirus Res. 2018 Jun;5:87-88. PMID: 29499389 |
| Konno R., Konishi H., Sauvaget C., Ohashi Y., Kakizoe T. Effectiveness of HPV vaccination against high grade cervical lesions in Japan. Vaccine. 2018 Dec 18;36(52):7913-7915. PMID: 29778520 |
| Robles C., Wiesner C., Martinez S., Salgado Y., Hernandez M., Lucas E., Lineros J., Romero P., Herrero R., Almonte M., Murillo R. Impact of operational factors on HPV positivity rates in an HPV-based screening study in Colombia. Int J Gynaecol Obstet. 2018 Oct;143(1):44-51. PMID: 29944728 |
| Sankaranarayanan R., Joshi S., Muwonge R., Esmy P.O., Basu P., Prabhu P., Bhatla N., Nene B.M., Shaw J., Poli U.R.R., Verma Y., Zomawia E., Pimple S., Tommasino M., Pawlita M., Gheit T., Waterboer T., Sehr P., Pillai M.R.; Indian HPV vaccine study group. Can a single dose of human papillomavirus (HPV) vaccine prevent cervical cancer? Early findings from an Indian study. Vaccine. 2018 Aug 6;36(32 Pt A):4783-4791. PMID: 29551226 |
| Smelov V., Muwonge R., Sokolova O., McKay-Chopin S., Eklund C., Komyakov B., Gheit T. Beta and gamma human papillomaviruses in anal and genital sites among men: prevalence and determinants. Sci Rep. 2018 May 29;8(1):8241. PMID: 29844517 |
| Ursu R.G., Danciu M., Spiridon I.A., Ridder R., Rehm S., Maffini F., McKay-Chopin S., Carreira C., Lucas E., Costan V.V., Popescu E., Cobzeanu B., Ghetu N., Iancu L.S., Tommasino M., Pawlita M., Holzinger D., Gheit T. Role of mucosal high-risk human papillomavirus types in head and neck cancers in Romania. PLoS One. 2018 Jun 25;13(6):e0199663. PMID: 29940024 |
| Garland S. M., Brotherton J. M. L., Moscicki A. B., Kaufmann A. M., Stanley M., Bhatla N., Sankaranarayanan R., de Sanjose S., Palefsky J. M. HPV vaccination of immunocompromised hosts. Papillomavirus Res; 2017; 35-38. PMID: 29179867 |
| Gheit T., Anantharaman D., Holzinger D., Alemany L., Tous S., Lucas E., Prabhu P.R., Pawlita M., Ridder R., Rehm S., Bogers J., Maffini F., Chiocca S., Lloveras B., Kumar R.V., Somanathan T., de Sanjose S., Castellsague X., Arbyn M., Brennan P., Sankaranarayanan R., Pillai M.R., Gangane N., Tommasino M.; HPV-AHEAD study group. Role of mucosal high-risk human papillomavirus types in head and neck cancers in central India. Int J Cancer. 2017 Jul 1;141(1):143-151. PMID: 28369859 |
| Mena M., Lloveras B., Tous S., Bogers J., Maffini F., Gangane N., Kumar R.V., Somanathan T., Lucas E., Anantharaman D., Gheit T., Castellsague X., Pawlita M., de Sanjose S., Alemany L., Tommasino M.; HPV-AHEAD study group. Development and validation of a protocol for optimizing the use of paraffin blocks in molecular epidemiological studies: The example from the HPV-AHEAD study. PLoS One. 2017 Oct 16;12(10) PMID: 29036167 |
| Mittal S., Basu P., Muwonge R., Banerjee D., Ghosh I., Sengupta M.M., Das P., Dey P., Mandal R., Panda C., Biswas J., Sankaranarayanan R. Risk of high grade precancerous lesions and invasive cancers in high risk HPV positive women with normal cervix or CIN 1 at baseline - a population based cohort study. Int J Cancer. 2017;140(8):1850-1859. PMID: 28108997 |
| Roychowdhury A., Samadder S., Islam M.S., Chaudhury K., Roy A., Banerjee D., Mandal R., Basu P.S., Roychoudhury S., Panda C.K. Identification of Changes in the Human Papilloma Virus 16 (HPV16) Genome During Early Dissemination of Cervical Cancer Cells May Complement Histological Diagnosis of Lymph Node Metastasis. Pathol Oncol Res. 2017 Jan 19. PMID: 28101801 |
| Sangrajrang S., Laowahutanont P., Wongsena M., Muwonge R., Karalak A., Imsamran W., Senkomago V., Sankaranarayanan R. Comparative accuracy of Pap smear and HPV screening in Ubon Ratchathani in Thailand. Papillomavirus Res; 2017; 30-35. PMID: 28720454 |
| Zhang Q., Dong L., Hu S., Feng R., Zhang X., Pan Q., Ma J., Zhang L., Zhao X., Sankaranarayanan R., Qiao Y., Zhao F. Risk stratification and long-term risk prediction of E6 oncoprotein in a prospective screening cohort in China. Int J Cancer; 2017; 141(6): 1110-1119. PMID: 28560716 |
| Basu P., Banerjee D., Mittal S., Mandal R., Ghosh I., Das P., Muwonge R., Biswas J. Evaluation of a compact, rechargeable, magnifying device to triage VIA and HPV positive women in a cervical cancer screening program in rural India. Cancer Causes Control. 2016;27(10):1253-9. PMID: 27581249 |
| Basu P., Bhatla N., Ngoma T., Sankaranarayanan R. Less than 3 doses of the HPV vaccine - Review of efficacy against virological and disease end points. Hum Vaccin Immunother. 2016;12(6):1394-402. PMID: 26933961 |
| Basu P., Muwonge R., Mittal S., Banerjee D., Ghosh I., Panda C., Mandal R., Sankaranarayanan R. Implications of semi-quantitative HPV viral load estimation by Hybrid capture 2 in colposcopy practice. J Med Screen. 2016;23(2):104-10. PMID: 26566949 |
| Mittal S., Mandal R., Banerjee D., Das P., Ghosh I., Panda C., Biswas J., Basu P. HPV detection-based cervical cancer screening program in low-resource setting: lessons learnt from a community-based demonstration project in India. Cancer Causes Control. 2016;27(3):351-8. PMID: 26712612 |
| Sankaranarayanan R., Bhatla N., Basu P. Current global status & impact of human papillomavirus vaccination: Implications for India. Indian J Med Res. 2016;144(2):169-80. PMID: 27934795 |
| Sankaranarayanan R., Prabhu P. R., Pawlita M., Gheit T., Bhatla N., Muwonge R., Nene B. M., Esmy P. O., Joshi S., Poli U. R., Jivarajani P., Verma Y., Zomawia E., Siddiqi M., Shastri S. S., Jayant K., Malvi S. G., Lucas E., Michel A., Butt J., Vijayamma J. M., Sankaran S., Kannan T. P., Varghese R., Divate U., Thomas S., Joshi G., Willhauck-Fleckenstein M., Waterboer T., Muller M., Sehr P., Hingmire S., Kriplani A., Mishra G., Pimple S., Jadhav R., Sauvaget C., Tommasino M., Pillai M. R. Immunogenicity and HPV infection after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre prospective cohort study. Lancet Oncol. 2016;17(1):67-77. PMID: 26652797 |
| Santesso N., Mustafa R. A., Schunemann H. J., Arbyn M., Blumenthal P. D., Cain J., Chirenje M., Denny L., De Vuyst H., Eckert L. O., Forhan S. E., Franco E. L., Gage J. C., Garcia F., Herrero R., Jeronimo J., Lu E. R., Luciani S., Quek S. C., Sankaranarayanan R., Tsu V., Broutet N. (2016) World Health Organization Guidelines for treatment of cervical intraepithelial neoplasia 2-3 and screen-and-treat strategies to prevent cervical cancer. Int J Gynaecol Obstet; 132(3):252-8. PMID: 26868062 |
| Basu P., Mittal S., Banerjee D., Singh P., Panda C., Dutta S., Mandal R., Das P., Biswas J., Muwonge R., Sankaranarayanan R. Diagnostic accuracy of VIA and HPV detection as primary and sequential screening tests in a Cervical Cancer Screening Demonstration Project in India. Int J Cancer. 2015;137(4):859-67. PMID: 25631198 |
| Sankaranarayanan R. HPV vaccination: the most pragmatic cervical cancer primary prevention strategy. Int J Gynaecol Obstet. 2015;131 Suppl 1:S33-S5. PMID: 26433502 |
| Arrossi S., Maceira V., Paolino M., Sankaranarayanan R. Acceptability and uptake of HPV vaccine in Argentina before its inclusion in the immunization program: a population-based survey. Vaccine. 2012;30(14):2467-74. PMID: 22266289 |
| Pimple S., Muwonge R., Amin G., Goswami S., Sankaranarayanan R., Shastri S.S. Cytology versus HPV testing for the detection of high-grade cervical lesions in women found positive on visual inspection in Mumbai, India. Int J Gynaecol Obstet. 2010;108(3):236-9. PMID: 19945105 |
| Sankaranarayanan R. HPV vaccination: the promise & problems. Indian J Med Res. 2009;130(3):322-6. PMID: 19901441 |
| Sankaranarayanan R., Nene B.M., Shastri S.S., Jayant K., Muwonge R., Budukh A.M., Hingmire S., Malvi S.G., Thorat R., Kothari A., Chinoy R., Kelkar R., Kane S., Desai S., Keskar V.R., Rajeshwarkar R., Panse N., Dinshaw K.A. HPV screening for cervical cancer in rural India. N Engl J Med. 2009;360(14):1385-94. PMID: 19339719 |
| Shastri S.S., Dinshaw K., Amin G., Goswami S., Patil S., Chinoy R., Kane S., Kelkar R., Muwonge R., Mahe C., Ajit D., Sankaranarayanan R. Concurrent evaluation of visual, cytological and HPV testing as screening methods for the early detection of cervical neoplasia in Mumbai, India. Bull World Health Organ. 2005;83(3):186-94. PMID: 15798842 |
Book chapters:
| 2011 Sankaranarayanan R., Jivarajani P., Joshi S. Chapter 9. HPV Vaccination in Primary Prevention of Cervical Cancer. In: Rajaram S., Chitrathara K., Maheswari A. (eds). Cervical Cancer Contemporary Management. New Delhi: Jaypee Brothers Medical Publishers (P) LTD. 2011, pp. 66-73. |
| 2008 Sankaranarayanan R, Sauvaget C. HPV vaccination in the developing world. In: Stern PL, Kitchener HC, editors. Vaccines for the Prevention of Cervical Cancer. 2008. p. 103-13. |